Found 115 matching trials
RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma NA This study intends to evaluate the efficacy and safety of Transarterial emb...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Pilot Study of "OncozeneTM" Microspheres for Intra-arterial Delivery of Doxorubicin PHASE2 This is a pilot study of Onconzene Microspheres for intra-arterial delivery...
Show More Location
UT Southwestern Medical Center
Learn More & Join Trial
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma PHASE1 The phase I/II, double-blind, randomized study will investigate the efficac...
Show More Location
Kaohsiung Veterans General Hospital
Learn More & Join Trial
CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC N/A This retrospective multicenter study aims to evaluate whether radiographic ...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer PHASE2 This randomized phase II trial studies how well transarterial chemoemboliza...
Show More Location
Multiple Locations
Learn More & Join Trial
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma PHASE2 Transarterial chemoembolization (TACE) is widely used for unresectable hepa...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery PHASE2 RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow t...
Show More Location
Northwestern University, Northwestern Memorial Hospital
Learn More & Join Trial
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma PHASE2 Background:
Hepatocellular carcinoma (HCC) is the fifth most common cancer...
Show More Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid N/A Liver cancer is the sixth most common malignant tumor worldwide and the thi...
Show More Status
Active Not Recruiting
Location
Eastern Hepatobiliary Surgery Hospital, Naval Medical University,
Learn More & Join Trial
Combination Treatment for Advanced Liver Cancer PHASE3 The purpose of this study is to determine whether TACE combined endovascula...
Show More Location
Department of Interventional Radiology, Zhongshan Hospital, Fudan University
Learn More & Join Trial